By this approach, we analyzed 24,000 CD19+ cells from HD (n = 16 samples), 14,283 CD19+ cells from LTBI individuals (n = 10 samples), and 22,500 CD19+ cells from active TB patients (n = 14 samples) and combined all samples into one integrated dataset. Here, CD19 is linked to tuberculosis.